Inactief instrument

Andere talen Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE

Aandelen

Clal Biotechnology Industries Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	31/03
Clal Biotechnology Industries Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	16-08-23
Clal Biotechnology Industries Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	23-05-21
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 24.999999 million in funding from Meitav Dash Providence and Pension Ltd.	11-07-17
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 5 million in funding	12-04-17
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 20 million in funding from Yelin Lapidot Provident Funds Management Ltd., Yelin Lapidot - Mutual Funds Management Ltd.	09-04-17
Clal Biotechnology Seeks Investments	04-04-17
Clal Biotechnology Industries Ltd. Appoints Ofer Gonen as Permanent CEO	07-03-17
Clal Biotechnology Industries Ltd. Appoints Julian Adams Ph.D. as President and Chief Science Officer	23-01-17
Investment Arm of Cybele Investment House Ltd and Investment Arm of Victor Tshuba & Co. Law Office acquired 58% stake in D-Pharm LTD. from Clal Biotechnology Industries Ltd. for ILS 0.31 million.	06-09-16

Geen resultaten voor deze zoekopdracht